ABSTRACT
BACKGROUND AND PURPOSE: The current Neck Imaging Reporting and Data System (NI-RADS) criteria were designed for contrast-enhanced CT with or without PET. Prior studies have revealed the capability of DWI and T2 signal intensity in distinguishing locoregional tumor residual and recurrence from posttreatment benign findings in head and neck cancers. We aimed to propose MR imaging NI-RADS criteria by adding diffusion criteria and T2 signal intensity to the American College of Radiology NI-RADS template. MATERIALS AND METHODS: This retrospective study included 69 patients with head and neck squamous cell carcinoma (HNSCC) who underwent posttreatment contrast-enhanced MRI imaging surveillance using a 1.5T scanner. The scans were interpreted by 2 neuroradiologists. Image analysis assessed the primary tumor site using the current American College of Radiology NI-RADS morphologic lexicon (mainly designed for contrast-enhanced CT with or without PET). NI-RADS rescoring was then performed based on our proposed criteria using T2 signal and diffusion features. The reference standard was a defined set of criteria, including clinical and imaging follow-up and pathologic assessment. RESULTS: Imaging assessment of treated HNSCC at the primary tumor site using T2 signal intensity and diffusion features as modifying rules to NI-RADS showed higher sensitivity, specificity, positive predictive value, negative predictive value, and accuracy (92.3%, 90.7%, 85.7%, 95.1%, and 91.3%, respectively) compared with the current NI-RADS lexicon alone (84.6%, 81.4%, 73.3%, 89.8%, and 82.6%, respectively). CONCLUSIONS: The addition of diffusion features and T2 signal to the American College of Radiology NI-RADS criteria for the primary tumor site enhances the specificity, sensitivity, positive predictive value, negative predictive value, and NI-RADS accuracy.
Subject(s)
Head and Neck Neoplasms , Squamous Cell Carcinoma of Head and Neck , Head and Neck Neoplasms/diagnostic imaging , Humans , Magnetic Resonance Imaging , Neoplasm Recurrence, Local/diagnostic imaging , Retrospective Studies , Squamous Cell Carcinoma of Head and Neck/diagnostic imagingABSTRACT
1. The effect of the volatile oil (VO) of the black seed (Nigella sativa) on the respiratory system of the urethane-anaesthetized guinea-pig was investigated and compared with those of its constituent thymoquinone (TQ). 2. Intravenous administration of VO in the dose range (4-32 microliters kg-1) induced dose-dependent increases in the respiratory rate and the intratracheal pressure. 3. The effects of VO were significantly antagonized by treatment of the animals with mepyramine, atropine and reserpine. They were not antagonized by indomethacin, diethyl carbamazine or hydrocortisone. 4. Intravenous administration of TQ in the dose range (1.6-6.4 mg kg-1) induced significant increases in the intratracheal pressure without any effect in the respiratory rate. 5. The results suggested that VO-induced respiratory effects were mediated via release of histamine with direct involvement of histaminergic mechanisms and indirect activation of muscarinic cholinergic mechanisms. 6. Removal of TQ from VO may provide a potential centrally acting respiratory stimulant.
Subject(s)
Plant Oils/pharmacology , Plants, Medicinal/chemistry , Respiration/drug effects , Animals , Benzoquinones/pharmacology , Guinea Pigs , In Vitro Techniques , Injections, Intravenous , Male , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Pressure , Receptors, Drug/antagonists & inhibitors , Reserpine/pharmacology , Saudi Arabia , Stimulation, Chemical , Trachea/drug effectsABSTRACT
1. The effects of the volatile oil (V.O.) of the black seed (Nigella sativa) on the arterial blood pressure and heart of urethane-anaesthetized rats were investigated and the effects were compared with those of its constituent thymoquinone (T.Q.). 2. Intravenous administration of V.O. in the dose range (4-32 microliters kg.-1) or T.Q. (0.2-1.6 mg kg-1) to rats decreased the arterial blood pressure and the heart rate in a dose-dependent manner. 3. The effects of V.O. were significantly antagonized by treatment of the animals with cyproheptadine, hexamethonium atropine and by spinal pithing. 4. Treatment of the animals with reserpine (5 mg kg- 1 day-1 for 2 days) significantly antagonized the cardiovascular depressant effects induced by 4 and 8 microliters of V.O. kg-1 but not those induced by the larger doses. 5. T.Q.-induced cardiovascular depressant effects were significantly antagonized by atropine and cyproheptadine but not by reserpine. 6. The results suggested that V.O.-induced cardiovascular depressant effects were mediated mainly centrally via indirect and direct mechanisms that involved both 5-hydroxytryptaminergic and muscarinic mechanisms. The direct mechanisms may be due to the presence of T.Q. in the V.O. The V.O. seemed to possess the potential of being a potent centrally acting antihypertensive agent.
